Affiliation:
1. Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, and
2. Office of Statistics and Programming, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia
Abstract
OBJECTIVE:
A voluntary market withdrawal of orally administered, over-the-counter, infant cough and cold medications (CCMs) was announced in October 2007. The goal of this study was to assess CCM-related adverse events (AEs) among children after the withdrawal.
METHODS:
Emergency department (ED) visits for CCM-related AEs among children <12 years of age were identified from a nationally representative, stratified, probability sample of 63 US EDs, for the 14 months before and after announcement of withdrawal.
RESULTS:
After withdrawal, the number and proportion of estimated ED visits for CCM-related AEs involving children <2 years of age were less than one-half of those in the prewithdrawal period (1248 visits [13.3%] vs 2790 visits [28.7%]; difference: −15.4% [95% confidence interval [CI]: −25.9% to −5.0%]), whereas the overall number of estimated ED visits for CCM-related AEs for children <12 years of age remained unchanged (9408 visits [95% CI: 6874–11 941 visits] vs 9727 visits [95% CI: 6649–12 805 visits]). During both periods, two-thirds of estimated ED visits involved unsupervised ingestions (ie, children finding and ingesting medications).
CONCLUSIONS:
ED visits for CCM-related AEs among children <2 years of age were substantially reduced after withdrawal of over-the-counter infant CCMs. Further reductions likely will require packaging improvements to reduce harm from unsupervised ingestions and continued education about avoiding CCM use for young children. Monitoring of CCM-related harm should continue because recommendations were updated in October 2008 to avoid the use of CCMs for children <4 years of age.
Publisher
American Academy of Pediatrics (AAP)
Subject
Pediatrics, Perinatology and Child Health
Reference31 articles.
1. Toxicity of over-the-counter cough and cold medications;Gunn;Pediatrics,2001
2. Over the counter but no longer under the radar: pediatric cough and cold medications;Sharfstein;N Engl J Med,2007
3. US Food and Drug Administration. Nonprescription Drug Advisory Committee Meeting: cold, cough, allergy, bronchodilator, antiasthmatic drug products for over-the-counter human use, October 18 and 19, 2007. Available at: www.fda.gov/ohrms/dockets/ac/07/briefing/2007-4323b1-02-FDA.pdf. Accessed May 3, 2010
4. What is the evidence for the safety and efficacy of over-the-counter cough and cold preparations for children younger than six years of age?;Dolansky;Paediatr Child Health,2008
5. Safety and efficacy of over-the-counter cough and cold medicines for use in children;Vassilev;Expert Opin Drug Saf,2010
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献